Learn More
Abnova™ Human PLAU (high molecular weight) native Protein from human urine
Shop All Abnova Corporation ProductsDescription
This gene encodes a serine protease involved in degradation of the extracellular matrix and possibly tumor cell migration and proliferation. A specific polymorphism in this gene may be associated with late-onset Alzheimer's disease and also with decreased affinity for fibrin-binding. This protein converts plasminogen to plasmin by specific cleavage of an Arg-Val bond in plasminogen. Plasmin in turn cleaves this protein at a Lys-Ile bond to form a two-chain derivative in which a single disulfide bond connects the amino-terminal A-chain to the catalytically active, carboxy-terminal B-chain. This two-chain derivative is also called HMW-uPA (high molecular weight uPA). HMW-uPA can be further processed into LMW-uPA (low molecular weight uPA) by cleavage of chain A into a short chain A (A1) and an amino-terminal fragment. LMW-uPA is proteolytically active but does not bind to the uPA receptor. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq]
Specifications
Specifications
Concentration | 3.27 mg/mL |
For Use With (Application) | SDS-PAGE |
Formulation | In 0.05M sodium acetate, 0.1M NaCl, pH 5.0 (1mM EDTA) |
Gene ID (Entrez) | 5328 |
Molecular Weight (g/mol) | 54kDa |
Name | PLAU (Human) Native Protein |
Preparation Method | Native protein purified from human urine |
Purification Method | Column chromatography using several resins |
Quantity | 100 μg |
Storage Requirements | Store at -80°C. Aliquot to avoid repeated freezing and thawing. |
Show More |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.